Completed
A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease
NCT03084796
- Conditions
- COPD, Chronic Disease, Chronic Obstructive Pulmonary Disease, +7 more
- Locations
-
- Chiesi Investigational Site Birmingham, Alabama, United States
- Chiesi Investigational Site Dothan, Alabama, United States
- Chiesi Investigational Site Montgomery, Alabama, United States
- Chiesi Investigational Site Flagstaff, Arizona, United States